Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Crutchlow: Validation of steady-state insulin sensitivity indices in chronic kidney disease. (0.11 sec) 

Validation of steady-state insulin sensitivity indices in chronic kidney disease

- diabetesjournals.org
MF Crutchlow, B Robinson, B Pappachen, N … - Diabetes care, 2007 - Am Diabetes Assoc
Chronic kidney disease (CKD) affects up to 20 million Americans and has high
morbidity and mortality attributed to atherosclerotic cardiovascular disease
(CVD) (1–4). Prevention of CVD in this high-risk population depends on ...
Cited by 4 - Related articles - BL Direct - All 6 versions

Validation of Steady State Insulin Sensitivity Indices in Chronic Kidney Disease Running Title …


MF Crutchlow, B Robinson, MD Binu … - Am Diabetes Assoc
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine,and
the Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania,
Philadelphia, Pennsylvania 2Renal Electrolyte and Hypertension Division, ...
Related articles

Otozomal Dominant Polikistik Böbrek Hastalığında Diyaliz Tedavisi


HK ERGİN - Nefroloji Dergisi, 2005 - turkiyeklinikleri.com
Otosomal dominant polikistik böbrek hastalığında diyaliz tedavisi ihtiyacı
genellikle ileri yaşlarda oluşur. Hastaların yaşam süresi, diğer böbrek
hastalıkları nedeni ile hemodiyaliz tedavisi gören hastalardan %10-15 ...
Cited by 1 - Related articles - Cached - All 7 versions

Glucose metabolism in early renal failure


C Catena, G Soardo, A Melis, S De Marchi, LA … - American Journal of Kidney Diseases, 2005 - Elsevier
Insulin resistance could contribute to cardiovascular risk in renal patients.
Precise definition of the stage at which it manifests is important for
appropriate risk stratification and management of these patients.
Cited by 2 - Related articles - All 12 versions

Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, …


M Di Mauro, G Papalia, R Le Moli, B Nativo, F … - Diabetes research and clinical practice, 2001 - Elsevier
Aim of this study was to investigate whether octreotide, a synthetic
somatostatin analogue that inhibits growth hormone, insulin and glucagon
secretion and improves glycaemic control in insulin dependent diabetic ...
Cited by 2 - Related articles - All 8 versions

[CITATION] Outcome of renal replacement therapy in autosomal dominant polycstic kidney disease


Y Pırson, JL Christophe, E Goffin - Nephrol Dial Transplant, 1996
Cited by 2 - Related articles

[CITATION] Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells


NSMA FJ, Y Luo… - Nat Genet, 2003
Cited by 2 - Related articles

The emerging biology of adipose tissue in chronic kidney disease: from fat to facts

- oxfordjournals.org
J Axelsson - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA
Regardless of the implications, the incidence of obesity is increasing worldwide
[1] and along with it the proportion of the population subject to hypertension
[1] or type-2 diabetes mellitus [1]. Furthermore, the metabolic syndrome is ...
Cited by 3 - Related articles - All 9 versions

[CITATION] Volume changes in autosomal dominant polycystic kidneys after the initiation of …


I Ishikawa, Y Saito - Nephron, 1993 - cat.inist.fr
VOLUME CHANGES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEYS AFTER THE INITIATION OF
HEMODIALYSIS. I ISHIKAWA, Y SAITO Nephron 65:44, 649-650, Karger, 1993.
Cited by 3 - Related articles - BL Direct - All 5 versions

[CITATION] Mechanisms of disease: Polycystic kidney disease


PD Wilson - New England Journal of Medicine, 2004 - MEDICAL PUBLISHING GROUP-MASS MEDIC SOCIETY
Cited by 4 - Related articles - BL Direct


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google